03521nas a2200409 4500000000100000008004100001260001000042653001900052653000800071653001300079653001700092653001400109653002100123653001700144653002000161653002400181653002000205653002400225100001100249700002300260700001800283700001900301700002800320700002500348700002200373700002900395700001500424700002200439700002500461700002400486700002400510245015600534856006300690300000900753520232400762022002503086 2024 d bWiley10aChagas disease10aHIV10aMigrants10aPrimary care10aScreening10aStrongyloidiasis10aTuberculosis10aViral hepatitis10aInfectious diseases10aSchistosomiasis10aImported infections1 aCruz A1 aSequeira‐Aymar E1 aGonçalves AQ1 aCamps‐Vila L1 aMonclús‐González MM1 aRevuelta‐Muñoz EM1 aBusquet‐Solé N1 aSarriegui‐Domínguez S1 aCasellas A1 aCuxart‐Graell A1 aRosa Dalmau Llorca M1 aAguilar‐Martín C1 aRequena‐Méndez A00aEpidemiology of infectious diseases in migrant populations from endemic or high‐endemic countries: A multicentric primary care‐based study in Spain uhttps://onlinelibrary.wiley.com/doi/epdf/10.1111/tmi.14036 a1-133 a

Objectives: We aimed to evaluate the epidemiology of seven infections (Chagas disease, strongyloidiasis, schistosomiasis, human immunodeficiency virus, hepatitis B and C virus, and active tuberculosis) in migrant populations attended at primary care facilities in Catalonia, Spain.

Methods: This is a cross sectional study conducted from March to December 2018 at eight primary care centres in Catalonia, Spain where health professionals were recommended to systematically screen multiple infections in migrants considering the endemicity of the pathogens in their country of birth. Routine health data were retrospectively extracted from electronic health records of the primary care centres. The proportion of cases among individuals tested for each infection was estimated with its 95% confident interval (CI). Mixed‐effects logistics regression models were conducted to assess any possible association between the exposure variables and the primary outcome.

Results: Out of the 15,780 migrants that attended primary care centres, 2410 individuals were tested for at least one infection. Of the 508 (21.1%) migrants diagnosed with at least one condition, a higher proportion originated from Sub‐Saharan Africa (207, 40.7%), followed by South‐East Europe (117, 23.0%) and Latin‐America (88, 17.3%; p value <0.001). The proportion of migrants diagnosed with Chagas disease was 5/122 (4.1%, 95%CI 0.5–7.7), for strongyloidiasis 56/409 (13.7%, 95%CI 10.3–17.0) and for schistosomiasis 2/101 (2.0%, 95%CI 0.0–4.7) with very few cases tested. The estimated proportion for human immunodeficiency virus was 67/1176 (5.7%, 95%CI 4.4–7.0); 377/1478 (25.5%, 95%CI 23.3–27.7) for hepatitis B virus, with 108/1478 (7.3%, 95%CI 6.0–8.6) of them presenting an active infection, while 31/1433 (2.2%, 95%CI 1.4–2.9) were diagnosed with hepatitis C virus. One case of active tuberculosis was diagnosed after testing 172 migrant patients (0.6%, 95%CI 0.0–1.7).

Conclusions: We estimated a high proportion of the studied infections in migrants from endemic areas. Country‐specific estimations of the burden of infections in migrants are fundamental for the implementation of preventive interventions.

 a1360-2276, 1365-3156